BBOX1-AS1 competitively binds miR-361-3p, leading to the upregulation of E2F1 in pituitary adenoma [34], COL5A1 and COL1A1 in oesophageal carcinoma [41, 45], MUC13 in gastric cancer [48], SH2B1 in colorectal cancer [50], PHF8 in hepatocellular carcinoma [46], HOXC6 in cervical cancer [53], and PODXL in ovarian cancer [51], thereby promoting tumor cell proliferation, invasion and metastasis. Here, PHF8 is linked to neoplasm.